Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Deficit) (Tables)

v3.24.2.u1
Stockholders’ Equity (Deficit) (Tables)
9 Months Ended
Jun. 30, 2024
Equity [Abstract]  
Schedule of Warrants Outstanding

As of June 30, 2024, the following equity-classified warrants and related terms were outstanding:

 

    Warrants Outstanding     Exercise Price     Expiration Date  
Common stock warrants August 2021     112,429     $ 261.80       August 24, 2026  
Underwriter warrants August 2021     2,287     $ 327.25       August 19, 2026  
Chanticleer warrants     57     $ 18,018.00 - 28,028.00       April 30, 2027 - December 17, 2028  
Series C warrants     18,391     $ 982.52       October 16, 2025  
Series 3 warrants     12,548     $ 89.628       August 15, 2027  
Common stock warrants February 2023     271,883     $ 23.76       February 10, 2028  
Underwriter warrants February 2023     15,466     $ 29.70       February 8, 2028  
Common stock private placement warrants June 2023     227,272     $ 1.55       June 21, 2029  
Placement agent warrants June 2023     6,818     $ 14.8478       December 30, 2026  
Common stock warrants October 2023     2,840,000     $ 1.20       October 27, 2028  
Pre-funded warrants October 2023     797,500     $ 0.0001        
Underwriter warrants October 2023     85,312     $ 2.00       October 24, 2028  
Placement agent warrants June 2024     113,140     $ 1.86       June 19, 2029  
Common stock warrants June 2024     5,625,000     $ 1.55       June 21, 2029  
Total     10,128,103